These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30579866)

  • 21. Genetic deletion of CB
    Aso E; Andrés-Benito P; Ferrer I
    Biochem Pharmacol; 2018 Nov; 157():210-216. PubMed ID: 30096288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular and molecular biology of Alzheimer's disease and animal models.
    Price DL; Sisodia SS
    Annu Rev Med; 1994; 45():435-46. PubMed ID: 8198393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology?
    Muyllaert D; Kremer A; Jaworski T; Borghgraef P; Devijver H; Croes S; Dewachter I; Van Leuven F
    Genes Brain Behav; 2008 Feb; 7 Suppl 1():57-66. PubMed ID: 18184370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of transgenic animal models for Alzheimer's disease].
    Watanabe N; Tabira T
    No To Shinkei; 2001 Sep; 53(9):809-20. PubMed ID: 11596475
    [No Abstract]   [Full Text] [Related]  

  • 25. Alzheimer's amyloid story finds its star.
    Cole GM; Frautschy SA
    Trends Mol Med; 2006 Sep; 12(9):395-6. PubMed ID: 16880006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Animal models of Alzheimer's disease embrace diversity.
    Neff EP
    Lab Anim (NY); 2019 Sep; 48(9):255-259. PubMed ID: 31435040
    [No Abstract]   [Full Text] [Related]  

  • 27. New 'Alzheimer's mouse' produced.
    Marx J
    Science; 1996 Oct; 274(5285):177-8. PubMed ID: 8927978
    [No Abstract]   [Full Text] [Related]  

  • 28. The effects of enhanced zinc on spatial memory and plaque formation in transgenic mice.
    Linkous DH; Adlard PA; Wanschura PB; Conko KM; Flinn JM
    J Alzheimers Dis; 2009; 18(3):565-79. PubMed ID: 19584445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's disease-type brain abnormalities in animal models.
    Price DL; Martin LJ; Sisodia SS; Walker LC; Cork LC
    Prog Clin Biol Res; 1992; 379():271-87. PubMed ID: 1409750
    [No Abstract]   [Full Text] [Related]  

  • 30. Low-n oligomers as therapeutic targets of Alzheimer's disease.
    Ono K; Yamada M
    J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of apoE/Abeta interactions in Alzheimer's disease: insights from transgenic mouse models.
    Brendza RP; Bales KR; Paul SM; Holtzman DM
    Mol Psychiatry; 2002; 7(2):132-5. PubMed ID: 11840304
    [No Abstract]   [Full Text] [Related]  

  • 32. Steps towards a mouse model of Alzheimer's disease.
    Crowther RA
    Bioessays; 1995 Jul; 17(7):593-5. PubMed ID: 7646481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurobiology. Untangling Alzheimer's by paring plaques bolsters amyloid theory.
    Beckman M
    Science; 2004 Aug; 305(5685):762. PubMed ID: 15297635
    [No Abstract]   [Full Text] [Related]  

  • 34. Assembly of paired helical filaments from mouse tau: implications for the neurofibrillary pathology in transgenic mouse models for Alzheimer's disease.
    Kampers T; Pangalos M; Geerts H; Wiech H; Mandelkow E
    FEBS Lett; 1999 May; 451(1):39-44. PubMed ID: 10356980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease: Moving towards a vaccine.
    Holtzman DM
    Nature; 2008 Jul; 454(7203):418-20. PubMed ID: 18650906
    [No Abstract]   [Full Text] [Related]  

  • 36. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiota modulation counteracts Alzheimer's disease progression influencing neuronal proteolysis and gut hormones plasma levels.
    Bonfili L; Cecarini V; Berardi S; Scarpona S; Suchodolski JS; Nasuti C; Fiorini D; Boarelli MC; Rossi G; Eleuteri AM
    Sci Rep; 2017 May; 7(1):2426. PubMed ID: 28546539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent topics on Alzheimer's disease. Alzheimer's disease from the viewpoint of the free radical theory].
    Kobayashi K
    Nihon Rinsho; 1988 Jul; 46(7):1616-22. PubMed ID: 3221469
    [No Abstract]   [Full Text] [Related]  

  • 39. Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin.
    Zenaro E; Pietronigro E; Della Bianca V; Piacentino G; Marongiu L; Budui S; Turano E; Rossi B; Angiari S; Dusi S; Montresor A; Carlucci T; Nanì S; Tosadori G; Calciano L; Catalucci D; Berton G; Bonetti B; Constantin G
    Nat Med; 2015 Aug; 21(8):880-6. PubMed ID: 26214837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered synapses and gliotransmission in Alzheimer's disease and AD model mice.
    Mitew S; Kirkcaldie MT; Dickson TC; Vickers JC
    Neurobiol Aging; 2013 Oct; 34(10):2341-51. PubMed ID: 23643146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.